Variant report

Variant	esv10647
Chromosome Location	chr10:90794988-90803055
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 262 )
Associated
traits (count: 88 )

Variant overlapped rSNPs/rCNVs (count:262 , 50 per page) page: 1 2 3 4 5 6

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs150146464	chr10:90795003-90795004	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs564537349	chr10:90795011-90795012	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs528631851	chr10:90795028-90795029	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs546995684	chr10:90795032-90795033	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs568410135	chr10:90795047-90795048	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs112075539	chr10:90795052-90795053	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs80049281	chr10:90795070-90795071	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs550561806	chr10:90795112-90795113	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs186279849	chr10:90795163-90795164	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs539221723	chr10:90795167-90795168	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs147681378	chr10:90795175-90795176	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs566206126	chr10:90795185-90795186	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs10788629	chr10:90795204-90795205	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs142446250	chr10:90795212-90795213	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs573515606	chr10:90795224-90795225	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs544197450	chr10:90795243-90795244	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs190350137	chr10:90795301-90795302	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs182940481	chr10:90795325-90795326	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs569037945	chr10:90795378-90795379	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs559491431	chr10:90795392-90795393	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs546403202	chr10:90795410-90795411	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs146354041	chr10:90795412-90795413	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs539220540	chr10:90795416-90795417	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs567076265	chr10:90795458-90795459	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs186241283	chr10:90795493-90795494	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs562213056	chr10:90795529-90795530	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs377198772	chr10:90795545-90795546	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs529230281	chr10:90795572-90795573	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs75386884	chr10:90795601-90795602	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs77931304	chr10:90795605-90795606	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs533083601	chr10:90795706-90795707	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs551154054	chr10:90795708-90795709	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs56102605	chr10:90795709-90795710	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs572878536	chr10:90795712-90795713	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs386746357	chr10:90795721-90795722	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs71187086	chr10:90795722-90795723	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs191540522	chr10:90795796-90795797	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs79595633	chr10:90795804-90795805	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs538338162	chr10:90795884-90795885	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs556152845	chr10:90795887-90795888	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs10458738	chr10:90795907-90795908	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
42	rs546560329	chr10:90795912-90795913	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs73365618	chr10:90795974-90795975	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs79346160	chr10:90796006-90796007	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs35617163	chr10:90796057-90796058	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs34158968	chr10:90796060-90796061	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs561575114	chr10:90796110-90796111	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs7898005	chr10:90796151-90796152	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
49	rs562004069	chr10:90796227-90796228	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs574099219	chr10:90796240-90796241	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:88)

Disease	PMID	Source
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
Prostate cancer	18632612	CNVD
Cockayne syndrome	18421352	CNVD
Glioblastoma	16823260	CNVD
Medulloblastoma	16968546	CNVD
Neuroblastoma	17533364	CNVD
Squamous cell cancer	21044232	CNVD
Glioma	21971842	CNVD
Cancer	21637783	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Lung cancer	18438408	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Usher syndrome	20538994	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21785460	CNVD
Acute myeloid leukemia	20729466	CNVD
Prostate cancer	16573809	CNVD
Paraganglioma	17535989	CNVD
Submicroscopic aberration syndrome	21292638	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Pulmonary chondroma	17535989	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Colorectal cancer	18645599	CNVD
Polyposis syndrome	18645599	CNVD
Prostate cancer	17245344	CNVD
Glioblastoma multiforme	17369134	CNVD
Glioblastoma multiforme	21750150	CNVD
Breast cancer	22032731	CNVD
Ovarian cancer	20844748	CNVD
Glioblastoma multiforme	17002787	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	17387387	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21364760	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Wilms tumour	21544195	CNVD
Cancer	20164919	CNVD
small cell lung cancer	20016488	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Colorectal cancer	19359472	CNVD
Neurocytoma	17123091	CNVD
Prostate cancer	16461572	CNVD
Basal-like breast cancer	18066063	CNVD
Effusion lymphoma	18079361	CNVD
Lung cancer	21911935	CNVD
Myelofibrosis	22110671	CNVD
Prostate cancer	21088497	CNVD
Breast cancer	22048815	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Glioblastoma multiforme	22291905	CNVD
Glioblastoma multiforme	19435819	CNVD
Glioblastoma multiforme	22286061	CNVD
Intracranial ependymoma	16609018	CNVD
Breast cancer	16397240	CNVD
Chronic lymphocytic leukemia	21049055	CNVD
Cervical cancer	21062161	CNVD
Non-small cell lung cancer	21829676	CNVD
Melanoma	24453001	CNVD
Breast cancer	16608533	CNVD
Sezary syndrome	18413736	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Bipolar disorder	19114987	CNVD
Melanoma	17363583	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:74 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:90771800-90808600	Weak transcription	Primary T cells from cord blood	blood
2	chr10:90772400-90795000	Weak transcription	Placenta	Placenta
3	chr10:90772600-90795800	Weak transcription	Rectal Smooth Muscle	rectum
4	chr10:90780800-90804200	Weak transcription	Primary T cells fromperipheralblood	blood
5	chr10:90789800-90802000	Weak transcription	Ovary	ovary
6	chr10:90790000-90802800	Weak transcription	Fetal Intestine Small	intestine
7	chr10:90792000-90801800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
8	chr10:90792200-90807200	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
9	chr10:90792600-90795000	Weak transcription	Adipose Nuclei	Adipose
10	chr10:90792800-90795000	Weak transcription	Right Atrium	heart
11	chr10:90792800-90795000	Weak transcription	NHDF-Ad	bronchial
12	chr10:90792800-90795600	Weak transcription	NHLF	lung
13	chr10:90792800-90796800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
14	chr10:90792800-90801600	Weak transcription	Esophagus	oesophagus
15	chr10:90792800-90801800	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
16	chr10:90792800-90801800	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
17	chr10:90792800-90807200	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
18	chr10:90792800-90807400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
19	chr10:90792800-90814600	Weak transcription	GM12878-XiMat	blood
20	chr10:90793000-90795000	Weak transcription	Primary monocytes fromperipheralblood	blood
21	chr10:90793000-90795000	Weak transcription	Osteobl	bone
22	chr10:90793000-90796800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
23	chr10:90793000-90801800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
24	chr10:90793200-90795400	Weak transcription	Primary neutrophils fromperipheralblood	blood
25	chr10:90793200-90801600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
26	chr10:90793200-90801800	Weak transcription	HMEC	breast
27	chr10:90794000-90795000	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
28	chr10:90794200-90816800	Weak transcription	Left Ventricle	heart
29	chr10:90794600-90795000	Enhancers	HUES64 Cell Line	embryonic stem cell
30	chr10:90794800-90795000	Enhancers	iPS-18 Cell Line	embryonic stem cell
31	chr10:90794800-90796000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
32	chr10:90794800-90797800	Enhancers	Monocytes-CD14+_RO01746	blood
33	chr10:90795000-90795800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
34	chr10:90795000-90795800	Enhancers	Adipose Nuclei	Adipose
35	chr10:90795000-90795800	Enhancers	Placenta	Placenta
36	chr10:90795000-90795800	Enhancers	Right Atrium	heart
37	chr10:90795000-90795800	Enhancers	NHDF-Ad	bronchial
38	chr10:90795000-90796600	Enhancers	Primary monocytes fromperipheralblood	blood
39	chr10:90795400-90795800	Enhancers	Primary neutrophils fromperipheralblood	blood
40	chr10:90795600-90795800	Enhancers	H9 Cell Line	embryonic stem cell
41	chr10:90795800-90796800	Weak transcription	Primary neutrophils fromperipheralblood	blood
42	chr10:90795800-90801800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
43	chr10:90795800-90803800	Weak transcription	Right Atrium	heart
44	chr10:90796000-90807000	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
45	chr10:90796600-90797000	Weak transcription	Primary monocytes fromperipheralblood	blood
46	chr10:90796800-90797400	Enhancers	Primary neutrophils fromperipheralblood	blood
47	chr10:90796800-90797400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
48	chr10:90796800-90797600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
49	chr10:90797000-90798000	Enhancers	Primary monocytes fromperipheralblood	blood
50	chr10:90799600-90801000	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links